For Investors
- Analyst Coverage
- Annual Reports
- Calendar
- Contact Investor Relations
- Financial Reports
- Frequently Asked Questions
- Information Circular
- Management and Investor Relations
- Media Coverage
- News Releases
- Presentations
- Request Documents
- SEDAR Filings
- Stock Quote
- Webcasts
- Why Invest?
News Releases ::
-
Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and Commercialize Voclosporin in ChinaMore...August 24, 2010
-
Isotechnika reports second quarter 2010 financial resultsMore...August 11, 2010
-
Lux Biosciences receives Complete Response letter from FDA for voclosporinMore...August 4, 2010
Media Coverage ::
-
Pharma Watch: 3SBio, Isotechnika Partner on VoclosporinMore...August 25, 2010
-
Isotechnika lands China dealMore...August 25, 2010
-
Isotechnika Pharma signs $6m commercialization agreement for transplant organ rejection drug with 3SBio in ChinaMore...August 24, 2010
Events ::
-
Annual & Special MeetingMore...September 9, 2010
Request Documents
To receive information from Isotechnika Inc., please complete the below form.
Please note that items with * are required: